Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-09

FDA Approved: HEMABATE — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

FDA approved a supplemental application for HEMABATE (carboprost tromethamine) from Pharmacia & Upjohn Company LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemabate (carboprost trometamol)

Snippet

SUPPL AP for HEMABATE (CARBOPROST TROMETHAMINE)